Articles from Instem

Instem, a global leader in life sciences software solutions, today announced significant enhancements to its Provantis Pathology module, a cornerstone of the company’s industry-leading platform for preclinical study management. These latest innovations reflect Instem’s ongoing commitment to modernizing pathology workflows through advanced digitization and seamless integration.

Instem is excited to announce that it has closed on an acquisition of Strong Tower Solutions, a technology-enabled service provider with nearly 20 years of configuring and installing qualified, validated, and compliant statistical computing environment (SCE) systems. Strong Tower Solutions is a Pennsylvania-based company that provides technology solutions and services to life sciences customers proceeding through clinical trials.

Following the FDA’s recent announcement expanding flexibility in preclinical submission evidence, Instem is reaffirming its role as the industry’s trusted provider of an end-to-end preclinical platform - empowering life sciences organizations with the tools, insight, and scientific depth needed to thrive in an increasingly dynamic regulatory environment.

Instem, a global leader in IT solutions for life sciences, has announced the launch of its new Non-GLP Pathology Module for Provantis, the market share-leading in vivo preclinical study management solution. Trusted by a wide user base including pathologists, Provantis streamlines workflows and enables efficient data management. This new module is designed to eliminate inefficiencies and modernize pathology workflows. This cloud-hosted solution simplifies data entry, integrates seamlessly with Provantis, and delivers continuous updates for ongoing enhancements.

Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it will be showcasing its enhanced Provantis® Pathology solution at this year’s Society of Toxicologic Pathology (STP) Symposium June 16-19, in Baltimore, MD.

Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that its latest in silico solution offering known as Advance™ is providing clients with a technology-enabled approach for assessing carcinogenicity based on the ICH S1B Weight of Evidence (WoE) Addendum.

Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has been acquired by ARCHIMED as an integral part of the company’s mission to enable clients to bring their life enhancing products to market faster.

Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that the latest edition of its powerful Leadscope Model Applier Computational Toxicology software solution has been released.

Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has been awarded a European Medicines Agency (EMA) grant as part of an EMA-funded research project to better understand the mutagenicity of N-nitrosamines.

Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has further enhanced its Predict™ In Silico Toxicology service portfolio by adding four new services.

Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has acquired PDS Life Sciences (PDS) as part of its mission to enable clients to bring their life enhancing products to market faster. This further consolidation by Instem of key application areas will help customers streamline and accelerate their research and development processes, while enabling clients to access data from across the R&D continuum, increasing the power of current and future in silico modelling and prediction solutions.

Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that the latest edition of its Leadscope Model Applier computational toxicology software solution will be released in September, ahead of a number of key industry meetings. This latest release includes a comprehensive package of new and updated models and alerts to meet the growing market demand for in silico solutions.